Home
About Us
Seglin Technology
Programmes
Investors
News Centre
Careers
Contact Us
Site Information
Email Alerts
Disclaimer
Site Map
Home
...
Site Map
site map
Home
Email Alerts
Disclaimer
Site Map
About Us
About Summit
Our Strategy
Our People
Board of Directors
Management
Location
Seglin Technology
Introduction
The Opportunity
Origins of Seglins
Diversity by Design
Therapeutic Application
Seglin Publications
Partnering
Programmes
Pipeline
SMT C1100: DMD
Overview
FAQs
Articles & Publications
SMT 19969: C. difficile
SEGLIN Programmes
SMT C2100: Cancer
SMT 14224: Diabetes
SMT 15000: Biodefence
Alzheimer's disease
Infectious diseases
Rare diseases
Other Programmes
SMT D001 (Sialorrhoea)
SMT D002 (Seborrhoea)
Glaucoma / AMD
Tuberculosis Programme
Investors
Share Information
Shareprice Information
Major Shareholders
FAQs
Regulatory News
Financial Reports
Financial Calendar
Analyst coverage
Advisers
IR Contacts
AIM Rule 26
Corporate Governance
Registered Information
Email Alerts
2011 AGM
News Centre
Press Releases
2008
2007
2006
2005
2004
Events
Careers
Join Us
Current Vacancies
Contact Us
Location
Directions